STOCK TITAN
  1. Home
  2. Sec-filings
  3. HNGE
  4. [8-K] Hinge Health, Inc. Reports Material Event

Hinge Health (HNGE) commits to 119K-square-foot SF office through 2037

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) entered into a long-term office lease with 50 Beale Street LLC for approximately 119,278 rentable square feet at 300 Mission Street, San Francisco. The lease is expected to commence five business days after the August 18, 2026 execution date and is anticipated to expire on February 28, 2037.

Over the lease term, aggregate estimated base rent payments total approximately $86.0 million, with Hinge Health also responsible for its share of operating expenses, taxes, insurance, and other costs. The landlord will provide a $17.9 million tenant improvement allowance, and Hinge Health must post an $2.8 million irrevocable standby letter of credit. The lease includes one five-year renewal option and a one-time early termination right effective January 31, 2035, subject to conditions, including payment of a termination amount. The lease creates a direct financial obligation for the company.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Premises size 119,278 rentable square feet Office space at 300 Mission Street, San Francisco, California
Aggregate base rent $86.0 million Estimated base rent over the term of the lease
Tenant improvement allowance $17.9 million Allowance provided by the landlord for improvements to the premises
Letter of credit amount $2.8 million Irrevocable standby letter of credit securing Hinge Health’s lease obligations
Lease expiration date February 28, 2037 Anticipated expiration of the lease term
Early termination effective date January 31, 2035 Effective date of one-time early termination right, subject to conditions
Renewal option term five years One renewal option granted to the company under the lease
tenant improvement allowance financial
"The Landlord will provide a tenant improvement allowance totaling up to $17.9 million."
A tenant improvement allowance is a sum of money a landlord agrees to provide or reimburse so a tenant can customize or fit out leased space to their needs, like a home renovation budget paid upfront by the property owner. It matters to investors because it affects leasing attractiveness, upfront costs, rental income and the building’s long‑term value—larger allowances can speed occupancy but reduce short‑term cash flow and raise capital repair needs.
irrevocable standby letter of credit financial
"provide the Landlord with an irrevocable standby letter of credit in an amount of $2.8 million."
Emerging growth company regulatory
"Emerging growth company x o"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
off-balance sheet arrangement financial
"or an Obligation under an Off-Balance Sheet Arrangement of a Registrant."
An off-balance sheet arrangement is a financial commitment or asset that a company keeps out of its main financial statements so it does not show up as a direct asset or liability. Think of it like renting equipment or using a separate storage locker instead of putting the item in your home: the economic effects exist, but they aren’t listed on the company’s primary balance sheet. Investors care because these arrangements can hide risks, obligations or sources of cash flow that affect a company’s true financial strength and future performance.

FAQ

What new lease did Hinge Health, Inc. (HNGE) sign in August 2026?
Hinge Health entered into an office lease for 119,278 rentable square feet at 300 Mission Street, San Francisco, with 50 Beale Street LLC. The lease was executed on August 18, 2026 and is expected to commence five business days after execution.

What is the total base rent commitment under HNGE’s new lease?
The aggregate estimated base rent payments over the lease term are approximately $86.0 million. In addition to base rent, Hinge Health will pay its share of operating expenses, taxes, insurance, and other additional operating costs related to the premises.

How long is the lease term for Hinge Health’s new San Francisco office?
The lease is anticipated to expire on February 28, 2037. It also grants Hinge Health one five-year renewal option and a one-time early termination right effective January 31, 2035, subject to conditions including payment of a termination amount.

What incentives does Hinge Health (HNGE) receive under the new lease?
The landlord will provide a tenant improvement allowance totaling up to $17.9 million. This allowance is intended to fund improvements to the leased premises at 300 Mission Street, San Francisco, for Hinge Health’s use.

What security is required from HNGE under the new lease agreement?
To secure its obligations, Hinge Health must provide the landlord with an irrevocable standby letter of credit in the amount of $2.8 million. This letter of credit supports the company’s performance and payment obligations under the lease.

Does this lease create a direct financial obligation for Hinge Health?
Yes. The company disclosed that the lease creates a direct financial obligation, and the information about the lease terms and payments is incorporated into the disclosure regarding direct financial obligations and off-balance sheet arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
FALSE000167374300016737432026-08-182026-08-18

`-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________________
FORM 8-K
________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 18, 2026
________________________________________________________
Hinge Health, Inc.
(Exact name of Registrant as Specified in Its Charter)
________________________________________________________
Delaware001-4265781-1884841
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
455 Market Street, Suite 700
San Francisco, California
94105
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: (415) 726-2206
________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, par value $0.00001 per shareHNGENew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 1.01 Entry into a Material Definitive Agreement
On August 18, 2026, Hinge Health, Inc. (the “Company”) entered into an office lease agreement (the “Lease”) with 50 Beale Street LLC, a Delaware limited liability company (the “Landlord”), for approximately 119,278 rentable square feet located at 300 Mission Street, San Francisco, California (the “Premises”). The Lease is anticipated to commence five business days after the execution date of the Lease.
The aggregate estimated base rent payments due over the term of the Lease are approximately $86.0 million. In addition to base rent, the Company will be required to pay its share of operating expenses, taxes and insurance expenses, as well as other additional operating costs under the Lease. The Landlord will provide a tenant improvement allowance totaling up to $17.9 million. To secure its obligations under the Lease, the Company will be required to provide the Landlord with an irrevocable standby letter of credit in an amount of $2.8 million.
The Lease is anticipated to expire on February 28, 2037, and grants the Company one five-year renewal option and a one-time early termination right effective January 31, 2035, subject to certain conditions, including payment of a termination amount.
The foregoing description of the Lease is a summary only and is qualified in its entirety by the full and complete terms of the Lease, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2026.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Hinge Health, Inc.
Date:August 21, 2026By:/s/ James Budge
James Budge, Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents